NCT06537713View on ClinicalTrials.gov

Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

April 30, 2021

Conditions
Moderate Traumatic Brain InjuryTestican-1Ubiquitin
Interventions
DIAGNOSTIC_TEST

Testican-1

Testican-1 and ubiquitin can serve as early indicators for diagnosing worsening clinical course and mortality in patients with moderate traumatic brain injury.

Trial Locations (1)

34303

Kanuni SUltan Suleyman Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT06537713 - Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma | Biotech Hunter | Biotech Hunter